Mohammad Mahdi Nasiri, the CEO of the Health Insurance Organization of Iran, discussed the details of the removal of some medications from insurance coverage in an interview. He explained that this decision was made to focus financial resources on emergency and inpatient services.
Reason for the removal of medications from insurance coverage
According to Nasiri, several injectable medications and some serums have been removed from insurance coverage in the outpatient sector. This decision is due to the high costs of these medications, which can reach tens of millions of tomans in monthly consumption. With this change, the Health Insurance Organization aims to allocate its resources to services that have a greater need.
Impact on patients and healthcare services
The removal of these medications from insurance coverage can have significant impacts on patients. Patients who need these medications will have to consider alternative ways to cover their costs. In this situation, the Health Insurance Organization of Iran has announced that insurance coverage will continue for expensive medications with high consumption. This can provide some reassurance for patients that they will have insurance support for their essential medications.
Nasiri also added that these changes are aimed at improving the quality of healthcare services and public health. Given the financial constraints and rising treatment costs, these choices can lead to more optimal resource allocation within the country's health system.
